News and Events
Dietary glutamine may be linked to B-cell lymphomas in abdominal lymph nodes
Study provides evidence for different anatomic locations being linked to different biology in lymphoma.
Read MoreAligned Blog: Celebrating National Minority Health Month: Improving Health Through Culture, Communities and Connections
To celebrate National Minority Health Month, Brenda Adjei, Ed.D., M.P.A., Associate Director of CCR's Office of Healthcare Delivery and Equity Research, expands on this year's theme, "Be the Source for Better Health," and highlights some CCR researchers striving to make cancer care more equitable.
Read MoreJung-Min Lee elected to the American Society for Clinical Investigation
Jung-Min Lee, M.D., Senior Investigator in the Women’s Malignancies Branch, was elected to the American Society for Clinical Investigation. The organization seeks to support scientific efforts, educational needs and clinical aspirations of physician-scientists to improve the health of all people. Lee was selected for her merit as an internationally recognized expert in ovarian cancer and for being a highly respected clinician and physician-scientist.
Read MoreCCR researchers receive a range of HHS awards
Three CCR researchers received prestigious awards from the Department of Health and Human Services. They are being recognized for their excellence, dedication and achievements in their respective research fields.
Read MoreCCR researchers elected to the Association of American Physicians
Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, and Yves Pommier, M.D., Ph.D., Chief of the Developmental Therapeutics Branch, were elected as 2024 members of the Association of American Physicians. The organization seeks to inspire physician-led research across all fields of science and medicine to improve patient health care and the health of Americans.
Read MoreStudy sheds light on diversity of study participants at CCR
Diversity in clinical trials is critical for understanding how well a treatment may work in different populations. A new study describes representation based on sex, age and ethnicity in clinical trials done at CCR.
Read MoreCelebrating CCR Careers: Mark Gilbert, M.D.
Mark Gilbert, M.D., has been a neuro-oncologist for nearly four decades, working to find better treatments for people with rare brain and spine tumors. After nearly a decade at CCR as Chief of the Neuro-Oncology Branch, he is announcing his retirement.
Read MoreNIH researchers develop AI tool with potential to more precisely match cancer drugs to patients
In a proof-of-concept study published on April 18, 2024, in Nature Cancer, CCR researchers have developed an artificial intelligence (AI) tool that uses data from individual cells inside tumors to predict whether a person’s cancer will respond to a specific drug. The team, led by Eytan Ruppin, M.D., Ph.D., Chief of the Cancer Data Science Laboratory, suggests that such single-cell RNA sequencing data could one day be used to help doctors more precisely match cancer patients with drugs that will be effective in treating their cancer.
Read MoreJung-Min Lee appointed Senior Investigator at CCR
The CCR community congratulates Jung-Min Lee, M.D., who has been appointed as a Senior Investigator in the Women’s Malignancies Branch. Lee’s research focuses on developing targeted therapies for ovarian carcinoma. Her studies have identified key proteins of DNA damage response pathways as therapeutic targets, opening up possibilities for novel therapies for this disease. Her research also emphasizes the collection of patient samples to better understand treatment response and tumor biology.
Read MoreAligned Blog: Honoring Women's History
As Women's History Month comes to an end, Shauna Clark, Ph.D., Associate Director of CCR's Office of Equity and Inclusion, highlights some of the work being done at the NIH in support of the inclusion of women in research and clinical trials.
Read MoreClinical trial researching medication therapy for IDH2-mutated nasal cavity or skull base tumors
A clinical trial led by Charalampos S. Floudas, M.D., D.M.Sc., M.S., Assistant Research Physician in the Center for Immuno-Oncology, is researching targeted medication therapy for patients with IDH2-mutated tumors in the nasal cavity or skull base area.
Read More